Trellus Health plc
Company Profile
Trellus Health (AIM: TRLS) is a health services company delivering innovative, scientifically validated programs and technologies designed to facilitate the management of chronic conditions, improve health outcomes and lower the costs of care.
The Company is initially focused on inflammatory bowel disease (“IBD”), which includes the chronic incurable conditions of Crohn’s Disease and ulcerative colitis, but its whole-person approach to value- based care has potential utlity across many conditions.
Investor Access
Management will hold the company’s AGM on Friday 14 June 2024
Please check here for more information: https://www.londonstockexchange.com/news-article/TRLS/posting-of-annual-report-accounts-agm-notice/16479237Friday 14 June 2024 at 12pm
Event | Date |
Year End | 31 December |
Half Year End | 30 June |
Preliminary Results* | March / April |
Interim Results* | September |
AGM* | June |
* Months based on previous announcements of this kind